News from Zyme and the companies we work with.
Carterra advances lab-in-the-loop drug discovery through new scientific collaboration
Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery Salt Lake City, Utah, 07 October, [...]
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
o2h co-discovery to host second edition of the Cambridge x London Life Sciences Showcase, taking place on 13 January 2027 at 111 Minna Gallery, San Francisco Event is designed to [...]
Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery
· Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models · Peer-reviewed study will inform large-scale screen to identify inhibition targets with applications in rejuvenation and age-related [...]
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across two days focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including [...]
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety London, UK, 30 September 2026: Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through [...]
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologies Follows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform [...]
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
First new floor-standing centrifuge developed since the integration of himac into the Eppendorf Group SpinPro 8 R combines high-speed performance with up to 6 L capacity and a selection of [...]
Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy
Study published in ‘Expert Review of Ophthalmology’ demonstrates potential to predict both speed and direction of macular atrophy progression at an earlier stage Findings strengthen the application of DARC as [...]
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen [...]
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK funding Founding team and advisors bring expertise from Deep [...]
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applications Investment led by The FSE [...]
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people London, UK and San Sebastián, Spain – 9 SEPTEMBER 2026: EpilepsyGTx, a [...]
